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The current scenario regarding the widespread Zika virus (ZIKV) has resulted in
numerous diagnostic studies, specifically in South America and in locations where
there is frequent entry of travelers returning from ZIKV-affected areas, including
pregnant women with or without clinical symptoms of ZIKV infection. The World Health
Organization, WHO, announced that millions of cases of ZIKV are likely to occur in the
USA in the near future. This situation has created an alarming public health emergency of
international concern requiring the detection of this life-threatening viral candidate due
to increased cases of newborn microcephaly associated with ZIKV infection. Hence,
this review reports possible methods and strategies for the fast and reliable detection of
ZIKV with particular emphasis on current updates, knowledge, and new hypotheses that
might be helpful for medical professionals in poor and developing countries that urgently
need to address this problem. In particular, we emphasize liposome-based biosensors.
Although these biosensors are currently among the less popular tools for human disease
detection, they have become useful tools for the screening and detection of pathogenic
bacteria, fungi, and viruses because of their versatile advantageous features compared
to other sensing devices. This review summarizes the currently available methods
employed for the rapid detection of ZIKV and suggests an innovative approach involving
the application of a liposome-based hypothesis for the development of new strategies
for ZIKV detection and their use as effective biomedicinal tools.
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OVERVIEW: WHAT IS ZIKA AND HOW DID IT BECOME
EPIDEMIC?
Zika virus (ZIKV), the causative agent of the infectious disease Zika fever, is a positive-sense RNA
virus that belongs to the family Flaviviridae, genus Flavivirus, and is similar to Dengue virus
(DENV), yellow fever virus, Japanese encephalitis virus, and West Nile virus (Sikka et al., 2016).
ZIKV was first isolated from Rhesus macaques in Uganda in 1947. Previously, only sporadic cases
of negligible concern associated with human ZIKV infection were reported (Hayes, 2009). Now,
ZIKV infections have become epidemic throughout the world (Charrel et al., 2016).
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In the north-eastern states of Brazil, the public health
authorities recently confirmed autochthonous transmission of
ZIKV with the first known reported case of ZIKV infection in
mainland South America (Campos et al., 2015; Zanluca et al.,
2015), followed by 26 countries, including countries in the
European Union and the outermost regions of the Americas,
such as Barbados, Bolivia, Brazil, Colombia, Costa Rica, Curacao,
Dominican Republic, Ecuador, El Salvador, French Guiana,
Guadeloupe, Guatemala, Guyana, Haiti, Honduras, Jamaica,
Martinique, Mexico, Nicaragua, Panama, Paraguay, Puerto Rico,
Saint Martin, Suriname, the US Virgin Island, and Venezuela
(Pan American Health Organization [PAHO], 2016; World
Health Organization [WHO], 2016). An increased frequency
of ZIKV infection among world travelers has been reported
in European countries, including Austria, Denmark, Finland,
France, Germany, Ireland, Italy, Portugal, the Netherlands, Spain,
Sweden, Switzerland, and the UK (European Centre for Disease
Prevention [ECDC], 2016).
The virion of ZIKV consists of an approximately 11 kb
positive-sense RNA with a single capsid and two membrane-
associated envelope proteins (M and E) (Leyssen et al., 2000;
Daep et al., 2014; Charrel et al., 2016). Recent outbreaks of
ZIKV infections have become fatal on a daily basis in the
Americas, where this obscure viral candidate has been placed
at the forefront of global healthcare. The reported occurrences
of ZIKV infections are thought to be transmitted mainly by the
mosquito species Aedes aegypti and Aedes albopictus. Infections
have now dramatically increased in highly populated areas
of South, Central, and North America due to the increased
frequency of the international travel from Zika-infected areas
(Bogoch et al., 2016). Considering the calamity of ZIKV
infection, there is an urgent need to develop rapid detection
methods for ZIKV along with DENV, which shares common
clinical symptoms with ZIKV. The purpose of this review is to
provide a complete update of the various analytical methods
for virus detection, such as molecular, immunological, sensor-
based and other detection assays, along with the advantages
and limitations of these strategies. Furthermore, we suggest
innovative hypothetical approaches for the development of
liposome-based rapid detection assays for ZIKV detection, which
will provide new insight to medical professionals for controlling
this widespread epidemic virus candidate.
DIAGNOSTIC FEATURES AND
CHALLENGES
ZIKV, an emerging flavivirus, shares common clinical symptoms
with DENV and chikungunya virus (CHIKV). The outbreaks
caused by these viruses present a large number of diagnostic
challenges. The clinical manifestations of ZIKV involve similar
clinical symptoms to DENV and CHIKV, which include fever,
exanthema, conjunctivitis, retro-orbital headache, and arthralgia
(Cardoso et al., 2015). The diagnosis of viral infection has
specific management implications for medical personnel. The
identification of DENV requires a routine follow-up to examine
thrombocytes along with hematocrit, whereas for CHIKV,
chronic arthralgia should be assessed due to its high prevalence.
In the case of ZIKV, a detailed diagnosis of sexual and maternal-
fetal transmission should be performed to confirm the risk of
congenital microcephaly in newborn babies (Fauci and Morens,
2016). A variety of arboviral infections (arthropod-borne; DENV
is the most common arboviral infection) may have similar clinical
presentations; therefore, their circulation may be under-reported
if specific diagnostic tools have not been implemented. However,
there are several drawbacks in ZIKV diagnosis due to the lack of
availability of diagnostic tools and the frequent cross-reactivity
of antibodies between flaviviruses, which have resulted in several
limitations in the use of serology (Musso et al., 2015). Commonly,
no routine testing of virus cultures is performed, and an antigenic
detection test is lacking at present (Musso et al., 2015; Saiz et al.,
2016).
The symptoms of ZIKV infection usually tend to be mild, and
the initial symptoms can escape notice, reducing the opportunity
to collect a sample. Although the viremic period has not been
completely defined, viral RNA has been detected in serum after
the onset of symptoms up to day 10. In addition, RNA particles
of ZIKV have been detected in urine over an extended period
in the acute phase, leading to the possibility of considering an
alternative sample type. Evidence suggests that serum samples
should be taken during the first 5 days after the onset of
symptoms supported in some more detailed studies (Musso et al.,
2015). Symptoms of microcephaly associated with ZIKV during
the development of newborns in the uterus have been reported
(Oduyebo et al., 2016). For the diagnosis of infant microcephaly,
a complete analysis of head circumference is requested (Kallen,
2014), as the diagnostic parameters for severe microcephaly
include a head circumference more than 3 standard deviations
below the mean (Von der Hagen et al., 2014). Testing should
be performed in pregnant women with positive or inconclusive
results from ZIKV testing. If diagnostic parameters confirm
possibility of congenital ZIKV infection in an infant, further
clinical evaluation should be performed in follow-up. Fever is
a common presenting symptom in patients testing positive for
arboviruses due to their association with multiple illnesses; hence,
it is suggested to eliminate differential diagnoses (Kelser, 2016).
Patients with DENV and ZIKV present with temperatures>40◦C
and <38.5◦C, respectively. ZIKV is usually self-limiting, with
symptoms lasting 2 to 7 days. Jaundice is a distinguishing clinical
presentation of yellow fever virus and can aid in identifying
patients with ZIKV virus. The presence of nausea, vomiting,
and bleeding may be helpful in identifying DENV. Any of the
above symptoms in an individual who has been exposed to
ZIKV indicates the possibility of ZIKV infection, and immediate
serum testing should therefore be performed (Centers for Disease
Control and Prevention [CDC], 2015a,b).
AVAILABLE DETECTION METHODS FOR
ZIKV
Diagnosis of ZIKV in the laboratory is usually based on the
serum analysis employing viral RNA or antibody-based detection
assays (Al-Qahtani et al., 2016; Haug et al., 2016). However,
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molecular technique-based assays are considered more reliable
due to the cross-reactivity of IgM antibodies among the candidate
flaviviruses during serological analysis (Haug et al., 2016).
Consistent efforts are being made regarding the development
of various detection strategies for virus detection (Figures 1
and 2). However, there is still a need to search for and improve
upon more sensitive and reliable detection methods for the
challenging virus candidate ZIKV for daily diagnoses. Developed
and applied methods for the detection of ZIKV are listed in
Table 1.
Molecular Methods
Molecular detection of viruses is a two-step process that
includes virus detection in propagated cell culture and viral
genome-based detection through molecular amplification using
polymerase chain reaction (PCR)- or real-time PCR-based
detection methods. In propagated cells, the detection of a
virus is confirmed by its cytopathic effect in cell culture,
and positive results are confirmed using tissue culture with
an infectious dose 50 (TCID50) in plaque assays (Hamza
et al., 2011). During the last several years, there has been
FIGURE 1 | Developments in various pathogen detection strategies.
FIGURE 2 | Consistent major year-wise efforts in the development of detection assays for Zika virus.
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TABLE 1 | Methods available and applied for Zika virus detection.
Method Sample analyzed Virus strain Detection limit Reference
Real-time reverse
transcription-PCR
Serum specimens Flavivirus/Zika virus (ZIKV) Tested for positive/negative
samples
Lanciotti et al., 2008
Real-time reverse
transcription-PCR
Serum specimens Flavivirus/ZIKV Tested for positive/negative
samples
Lanciotti and Tesh, 2011
One step real-time reverse
transcription-PCR
Human serum ZIKV 0.05 plaque forming unit
(pfu) in less than 3 h
Faye et al., 2013
Viral metagenomic
next-generation sequencing
Amniotic fluid samples ZIKV Tested for positive/negative
samples
Calvet et al., 2016
Complementary DNA synthesis
followed by PCR
Human serum ZIKV 33.7 pfu/mL Faye et al., 2008
Recombinant polymerase
amplification assay
Virus culture Dengue virus (DENV) Analytical sensitivity
between 105 and 103 RNA
molecules
Wahed et al., 2015
Real-time-PCR Virus cell culture/Human
serum
Flavivirus/ZIKV 140 copies viral
RNA/reaction
Balm et al., 2012
Multiplex real-time reverse
transcription-PCR
Virus cell culture/Human
serum
Flavivirus/ZIKV/DENV/
Chikungunya virus
108 to 10 copies/µL for
ZIKV and from 108 to 102
copies/µL for Dengue-1
Waggoner et al., 2016
Real-time-PCR Saliva/Blood ZIKV Tested for positive/negative
samples
Musso et al., 2015
Genomic sequencing Serum/Blood/Amniotic fluid/
New born babies
ZIKV Tested for positive/negative
samples
Faria et al., 2016
Paper-based synthetic gene
networks
Virus cell culture (ZIKV RNA
genome)/Plasma samples
ZIKV 1.7 × 106 copies/mL Pardee et al., 2016
Zika-specific reverse
transcriptase-PCR
Human serum ZIKV No information available Charrel et al., 2016
Zika MAC-ELISA Virus cell culture/Human
serum
ZIKV No information available Centers for Disease Control
and Prevention [CDC],
2016a,b; Lanciotti et al., 2008
Indirect immunofluorescent assay Human serum ZIKV Tested for positive/negative
samples
Tappe et al., 2014
Antigen detection and
immunoglobulin M capture ELISA
Virus cell culture/Human
serum
Mosquitoes transmitted
virus/Yellow fever virus
1.0 × 103 pfu/100 mL Adungo et al., 2016
Real time-PCR Human urine ZIKV RNA Tested for positive/negative
test
Gourinat et al., 2015
Instrument-free point-of-care
molecular detection
(reverse-transcription
loop-mediated, isothermal
amplification assay)
Virus cell culture ZIKV 5 pfu Song et al., 2016
Streptavidin-magnetic
nanoparticles coupled
oligonucleotide detection based
on loop-mediated isothermal
amplification
Virus cell culture/Human
serum
ZIKV 1 aM synthetic ZIKV
oligonucleotide
Tian et al., 2016
Liposome-based detection assay Virus cell culture DENV 10 pfu/mL Baeumner et al., 2002
Multi-analyte single-membrane
biosensor
Virus cell culture/Human
serum
DENV 50 RNA molecules for
serotype 2, 500 RNA
molecules for serotypes 3
and 4, and 50,000 RNA
molecules for serotype 1
Zaytseva et al., 2004
a revolution in virus detection methods using real-time PCR
based assays, which can be performed rapidly and produce
specific, sensitive, and reproducible results for virus detection
at a very low concentration (Sanchez et al., 2007). All of
these parameters are interconnected and depend mostly on
the target sequences of primers and probes and provide
absolute specificity and a balance between high sensitivity,
broad reactivity, and reliability of quantification. (Seifi et al.,
2012).
Polymerase chain reaction-based methods have numerous
advantages compared with conventional assay methods, such
as rapidity, quantitative measurement, low contamination rates,
and easy standardization (Sanchez et al., 2007; Seifi et al., 2012).
Although a real-time reverse transcription PCR assay is available
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for the detection of Micronesian ZIKV strains in Africa and Asia,
it does not cover the genetic diversity and geographic distribution
of ZIKV (Hayes, 2009). Current diagnostic techniques for ZIKV
infection are time-consuming and are mainly based on specific
detection of antibodies or isolation of viruses from animals or
mosquitoes (Digoutte et al., 1992; Hayes, 2009; Faye et al., 2013).
However, standard PCR-based techniques such as real-time PCR
and quantitative real-time PCR provide a rapid, specific, and
sensitive method for early detection of ZIKV (Foy et al., 2014).
Faye et al. (2013) developed a quantitative real-time PCR assay
for the detection of ZIKV in mosquitoes in the field with high
analytical sensitivity. It was found that the assay was able to detect
37 ZIKV isolates. These findings confirmed that the use of real-
time reverse transcription PCR assays could be a useful tool for
the detection of ZIKV in virus pandemic areas where viruses
including DENV and CHIKV also occur (Faye et al., 2013).
Calvet et al. (2016) developed a real-time quantitative PCR
assay for the detection of ZIKV in pregnant women using
viral metagenomics and gene sequencing analysis. The real-time
quantitative PCR analysis confirmed that the developed assay was
able to detect ZIKV infection in amniotic fluid; however, the
same assay showed negative results for the detection of ZIKV
infection in urine and serum samples. Escadafal et al. (2014)
tested the efficacy of a recombinant polymerase amplification
assay for the detection of yellow fever virus using a nucleic acid
detection method, which confirmed positive results. Detection
of DENV was also confirmed using a recombinase polymerase
amplification assay, supporting the suggestion that this assay
could be a useful tool for the detection of ZIKV (Wahed et al.,
2015). Due to the rapid global increase in ZIKV and concern
about the rapid increase of microcephaly cases in newborns,
the development of specific and sensitive point-of-care-testing
methods has become a major public health priority (Sikka et al.,
2016). Because ZIKV shares a common platform of clinical
manifestation with DENV and CHIKV, a specific and sensitive
one-step real-time PCR assay was tested for the presence of
ZIKV in 88 Dengue and Chikungunya-negative sera samples
collected from the patients representing with DENV-like illness
in Singapore (Balm et al., 2012). The assay displayed specific
detection of ZIKV with a low detection limit (140 copies of
viral RNA), suggesting that this assay could be useful for viral
detection in a variety of environmental samples (Balm et al.,
2012). Recently, Waggoner et al. (2016) developed and evaluated
a multiplex real-time reverse transcription PCR assay for
simultaneous detection of ZIKV. The developed assay improved
the detection limit of ZIKV relative to the corresponding real-
time reverse transcription PCR assay, and 31 samples were found
to be positive for ZIKV (Waggoner et al., 2016). The findings of
this study suggested that improved sensitivity for ZIKV detection
is needed, given the low viremia detected in clinical samples
and the current lack of accurate alternative diagnostics, such as
serology (Lanciotti et al., 2008; Musso et al., 2015). Additionally,
the developed assay identified 17 co-infections in ZIKV-positive
patients, suggesting its potential for application as a multiplex
diagnostic test for viral detection.
Furthermore, Kilianski et al. (2016) developed an
unamplified RNA/complementary DNA (cDNA)-hybrid
nanopore sequencing assay for the detection of RNA viruses,
including Middle East respiratory syndrome, Venezuelan
equine encephalitis virus, Ebola, and ZIKV. The developed
method was able to detect Venezuelan equine encephalitis
virus within 3 hours of acquisition and achieved differentiation
from other viral genomes, facilitating strain-level identification.
Nanopore sequencing is a novel genomics technology, which
has potential applications for routine biosurveillance, clinical
diagnosis, and outbreak investigation of virus infections by
rapid sequencing of unamplified RNA/cDNA hybrids. Kilianski
et al. (2016) sequenced unamplified poly(A)-tailed viral RNA
using a rapid cDNA library preparation coupled with real-
time data analysis to determine its potential application for
pathogen genomic characterization. This approach for pathogen
identification and characterization differs from the previously
used methods on the MinION platform (Hoenen et al., 2016).
Biased techniques, such as amplicon sequencing, have proven
to be effective in complex sample backgrounds in which titers
of the target pathogen might be low, but such approaches limit
characterization to known pathogens and require additional viral
genome amplification (Wang et al., 2015; Quick et al., 2016).
The great potential of the use of a RNA/cDNA hybrid approach
in field studies has been confirmed in western Africa (Hoenen
et al., 2016; Quick et al., 2016). Generally, high virus titers in
clinical samples are necessary for virus detection before genome
sequencing, hence utilizing an RNA/cDNA hybrid approach
for genomic ZIKV characterization could be a feasible strategy,
especially for genomic library preparation and for reducing
the time required for strain-level identification (Faria et al.,
2016).
Although PCR-based molecular techniques have aided in the
easy detection of a variety of viruses, there are still several
limitations to these methods. It has been noted that these
methods are prone to miss detections, favoring false negative
results and requiring proper quality control measures. However,
precautions have been taken to overcome the problem of
inhibition, including sample dilution analysis, the use of a small
sample size, and adaptation of the PCR assay employing chemical
reagents such as Tween (Al-Soud and Radstrom, 2001; Rutjes
et al., 2005; Butot et al., 2007). Another limitation of PCR-based
methods is their inability to differentiate between infectious and
non-infectious viruses. Although several approaches have been
used to overcome this limitation, the utilization of integrated
systems based on the molecular detection of viruses after
cell culture infection is considered one of the most efficient
methodologies (Reynolds et al., 2001; Rodriguez et al., 2009).
Additionally, integrated cell culture-PCR assays allow rapid virus
detection with selective enumeration of infectious viruses, though
the long incubation period required to reveal a cytopathic effect
is a major limitation.
Paper-Based Synthetic Gene Networks
for ZIKV Detection
The aim of synthetic biology focuses on re-engineering of
the molecular components of cells to exploit the power of
biology for which molecular biologists have developed whole-cell
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biosensors, synthetic probiotic candidates, new drug sources,
green technology, and chemical resources (Zhang et al., 2012;
Torella et al., 2013; Fossati et al., 2014; Kotula et al., 2014). As
recently reported, paper disk diagnostic tools show significant
efficacy as rapid and low-cost screening tools for the screening
of blood, urine, and saliva samples for specific identification of
virus strains. The assay methodology is based on the color change
of a paper disk to purple, indicating the presence of virus, or
yellow, in the absence of virus. Recently, Pardee et al. (2016)
reported some biotechnological parameters that dramatically
lower costs and technical barriers in the development of synthetic
biology-based diagnostics. In this regard, programmable RNA
sensors referred to as “toehold switches” could be the first
technology to be rationally applied to bind virtually any sense
RNA sequence (Green et al., 2014). Second, a freeze-dried,
paper-based, cell-free protein expression platform allows the
application of these toehold switch sensors outside of laboratories
by providing an abiotic, sterile method for the distribution
and storage of genetic circuits at room temperature (Pardee
et al., 2014). Concerning the above findings, combination of
these techniques could provide a rapid and inexpensive platform
for the development of easy-to-use virus diagnostic sensors. In
the context of the ZIKV outbreak, paper-based sensors offer a
solution to the critical challenges involved in diagnosis of the
virus. Standard serological methodologies involving antibody
detection present limitations due to their cross-reactivity with
other flaviviruses detected in previously infected patients; thus,
nucleic acid-based and isothermal nucleic acid amplification
detection methods are recommended for accurate detection of
viruses (Lanciotti et al., 2008; Tappe et al., 2014; Zammarchi
et al., 2015). However, such techniques are relatively expensive,
require technical expertise to run and interpret, and involve
equipment that is incompatible with use in remote and low-
resource locations, where surveillance and containment are
critically needed.
Immunoassays
The current ZIKV outbreak represents a great threat specifically
for pregnant women. Because the antibody response during
the pregnancy stage may differ from that in non-pregnant
individuals, more precautions should be taken when determining
the ZIKV immune responses in pregnant women. In flavivirus
infections, immunoglobulin M (IgM) antibodies typically
develop within a few days after the onset of illness and can
generally be detected up to three months (Charrel et al., 2016).
In addition, immunoglobulin G (IgG) antibodies are developed
within a few days after development of IgM antibodies and can
be detected for several months.
Recently (February 26, 2016), the Centers for Disease
Control and Prevention (CDC) requested that a letter be issued
authorizing the emergency use of the Zika IgM antibody capture
enzyme-linked immunosorbent assay (Zika MAC-ELISA) for the
presumptive detection of ZIKV-specific IgM in human sera or
cerebrospinal fluid (Centers for Disease Control and Prevention
[CDC], 2016b). The Zika MAC-ELISA is employed for in vitro
qualitative detection of ZIKV-specific IgM antibodies in human
sera. In addition, testing of ZIKV has been applied based on CDC
clinical and epidemiological criteria for ZIKV which include
clinical signs and symptoms associated with ZIKV infection
and/or history of residence in or travel to a geographic region
with active ZIKV transmission at the time of travel or other
epidemiologic criteria that may indicate ZIKV testing (Centers
for Disease Control and Prevention [CDC], 2016a). As reported
previously, immune responses under ZIKV infection have only
been described in a small number of patients (n= 11), during the
ZIKV virus outbreak in Yap (Lanciotti et al., 2008). When MAC-
ELISA for IgM and capture ELISA for IgG with the whole viral
antigen (inactivated virus) and monoclonal antibodies (MAbs)
were applied, IgM was found to appear as soon as 3 days after
the onset of symptoms, while IgG appeared after 10 days in a
patient with no history of previous flavivirus infections (Johnson
et al., 2000; Martin et al., 2000). Subsequently, it became possible
to detect neutralizing antibodies against ZIKV as early as 5 days
after the onset of fever. Euroimmun (2016) has developed the
first complete test package for the serological detection of ZIKV
infections. The ELISAs and indirect immunofluorescence assays
allow the determination of specific antibodies (IgM, IgG) against
a variety of viruses in the blood of infected patients.
Huzly et al. (2016) reported that the use of putative cross
reacting sera in ELISA tests from patients with Euroimmun
anti-ZIKV IgG and IgM antibodies against ZIKV showed high
specificity, confirming the applicability of Euroimmun ELISA
for specific detection of virus in patients exposed previously
to flavivirus or vaccine. The results suggest that this ELISA
method could be an effective diagnostic tool for the screening
and counseling of patients with a possibility of ZIKV virus
infection, especially pregnant women and travelers commuting
from ZIKV-endemic regions (Huzly et al., 2016). To confirm
the ability of the ZIKV ELISA to detect ZIKV antibodies, Tappe
et al. (2014) analyzed serum samples collected from 10 patients
in Brazil suffering from acute ZIKV infection. Laboratory results
confirmed that the indirect immunofluorescent assay was able
to define immunofluorescent assay titers for anti-ZIKV IgM (1:
1,280 to 1: > 20,480) and anti-ZIKV IgG (1: 320 to 1: > 20,480)
(Tappe et al., 2014). These samples were previously confirmed to
be negative for IgM and IgG against DENV and for the DENV
nonstructural protein-1(DENV NS1) antigen.
Along with ZIKV and DENV, yellow fever is another acute
viral infection transmitted through mosquito bites. It is strongly
believed that the current emergence and re-emergence of yellow
fever and other arboviruses is partly attributed to the increased
migration of people from disease-endemic regions and the
expanding establishment of the vector. The use of flavivirus
antigens in the development of MAbs and diagnostic tests has not
been well documented (Vazquez et al., 2009; Nunes et al., 2011;
Okamoto et al., 2012; Kwallah et al., 2013; Escadafal et al., 2014).
The application of MAbs in immunoassays offers the advantage of
high specificity, due to their ability to bind to specific epitopes of
antigens. This specific binding is useful in reducing the incidence
of cross-reactivity, which is reported to negatively impact the
use of many serological kits (Modis et al., 2003, 2005). Adungo
et al. (2016) also reported the development, characterization,
and evaluation of MAbs to yellow fever virus. Diagnostic
application of these MAbs was tested in antigen detection and
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IgM capture ELISA. The results suggested that MAb-based
antigen detection ELISA enabled the detection of virus in 40
culture supernatants containing titers of approximately 1,000
plaque forming units (pfu). Concerning the above findings, the
developed approach can be applied for the development of
improved detection kits for ZIKV. One of the limitations of this
test is the possibility of false positive results in patients with a
history of infection with other flaviviruses. Additional testing of
equivocal and positive specimens and/or other patient-matched
specimens, as specified in the CDC-issued algorithm, is therefore
required to confirm ZIKV infection (Centers for Disease Control
and Prevention [CDC], 2016a).
Magnetic Nanoparticles-Based Assays
Zika fever is a zoonotic infection caused by ZIKV, which shares
the limelight with other well-known members of the flavivirus
family, such as DENV, yellow fever virus, West Nile virus, and
Japanese encephalitis virus (Tilak et al., 2016). Consequently,
there is an urgent need to develop effective methods for the
surveillance of ZIKV. As ZIKV and DENV share sequential
homology, there is a high possibility that there may be detection
principles and vaccine development strategies that are applicable
to both viruses with some modifications.
One approach that could be useful for the detection of DENV
involves concentrating virus particles using ultracentrifugation
and polyethylene glycol-mediated precipitation. Although these
methods have been used successfully for variety of viruses,
ultracentrifugation shows numerous practical limitations, such
as the great amount of time required, which may increase the
false-positive rate when applied for PCR analysis (Roth et al.,
1999). Regarding polyethylene glycol-mediated precipitation,
although it is simple and easy to perform, it interferes with
subsequent PCR analysis (Novotny et al., 1992). A possible
alternative to these methods could be application of magnetic
beads coated with molecules that efficiently bind to the virus.
These beads allow viral particles to be captured and assist in
the concentration of viral particles through the application of
magnetic field.
A number of magnetic nanoparticles, such as iron, nickel,
or cobalt, have been successfully used for biomedical and
environmental applications due to their highly/specific surface
area and the ease of the magnetic collection of target materials
adsorbed by the magnetic nanoparticles (Safarikova and Safarik,
2001; Pankhurst et al., 2003). However, these beads generally
exhibit inherent chemical instability, limiting their application
in the fields of biological and environmental science (Saraswati
et al., 2012). To overcome this limitation, magnetic nanoparticles
have typically been encapsulated with a protective shell of
graphite, silica, or polymer for chemical stability (Saraswati
et al., 2012). Similarly, Sakudo et al. (2016) developed a
novel technology for the sensitive detection of DENV using
graphite-encapsulated magnetic nanoparticles conjugated with
anti-DENV antibody. Their assay method demonstrated that
antibody-integrated magnetic beads were useful for capturing
DENVs. The capturing of DENV1-4 using antibody-integrated
magnetic beads was confirmed by the results of the real-time
PCR analysis, showing that the captured fraction contained
DENV genomic RNA (Sakudo et al., 2016). Therefore, this
method may be used in combination with real-time PCR for
the detection of DENV and may increase the sensitivity of
viral detection for the diagnosis of DENV. Based on these
findings, it can be hypothesized that this methodology could
be extended for the accurate detection of ZIKV through the
immobilization of an anti-ZIKV antibody on the functionalized
surface of graphite magnetic nanoparticles. The modified
graphite magnetic nanoparticles can then be assessed for
their ability to capture ZIKV, and the concentrated virus can
subsequently be detected through the application of PCR-based
amplification procedure.
In the case of hydrophobic graphite-encapsulated magnetic
nanoparticles, which present limitations in various biomedical
applications, the particles can be modified appropriately
to achieve improved binding properties, allowing them to
efficiently recognize and bind to molecular targets, including
antibodies, antigens, and receptors (Poplawska et al., 2014).
Improvement of amino group functionalization can increase
the reactivity and hydrophobic nature of graphite particles
with the desirable functionality of graphite (Saraswati et al.,
2012). A promising method for the amino functionalization
of magnetic graphite nanoparticles could be to use inductively
coupled radiofrequency plasma, an environmentally friendly
method that requires a short duration for the reaction to
reach completion, thus effectively introducing amino groups
(Saraswati et al., 2011). Furthermore, alteration of plasma
discharge conditions can help to optimize the degree of surface
derivatization with the amino groups of graphite magnetic
nanoparticles. With these modifications of graphite magnetic
nanoparticles, efficient surface immobilization of antibodies
against various pathogens, including anti-influenza virus and
anti-Salmonella antibodies, could be achieved (Sakudo et al.,
2015).
Recently, Tian et al. (2016) developed an attomolar
ZIKV oligonucleotide detection method based on loop-
mediated isothermal amplification and susceptometry. It was
demonstrated that hydrodynamic volumes of streptavidin-
magnetic nanoparticles were dramatically increased after a
successful loop-mediated isothermal amplification reaction.
The hydrodynamic volumes are probed as Brownian relaxation
frequency shifts, which can be employed to quantify the ZIKV
oligonucleotide. The proposed detection system can recognize
1 aM synthetic ZIKV oligonucleotide in 20% serum with a total
assay time of 27 min. The results suggested that this could be
a promising strategy that may give rise to new possibilities for
diagnosing and controlling ZIKV infection.
With the increasing incidence of Dengue infection in
developing countries where DENV is endemic, the rapid
applicability of diagnostic tests is required for disease control.
Several immunological approaches have been applied for
laboratory diagnosis of DENV infection. These methods include
detection of the virus (by cell culture and immunofluorescence-
based), detection of virus antigen (by ELISA), detection of anti-
DENV antibody (by hemagglutination inhibition, complement
fixation test, and neutralization tests), and detection of virus
nucleic acid (by real-time reverse transcription-PCR). The
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hemagglutination inhibition is the most widely accepted
serological technique in developing countries; however, ELISA
has become the technique that is most often applied for the
serological diagnosis of DENV infection in DENV epidemic
regions due to its stability, simple handling procedure, and no
need of any complicated equipments.
Developments in the Liposome-Based
Detection of ZIKV/DENV
The characterization and detection of viruses is a labor-intensive
and time-consuming process. Upon the emergence of new viral
pathogens with a high frequency and catastrophic outbreaks,
there is always a need for improved detection and identification
methods to control the proliferation of these pandemic viral
candidates. Currently, at laboratory scale, only PCR-based
molecular techniques provide accurate detection of a variety of
viruses based on trial-and-error methods using a cell culture-
based procedure. PCR-based methods require thermal cycling
instruments and transformation of DENV/ZIKV genomic RNA
to DNA (Kow et al., 2001; Zaytseva et al., 2004). Zaytseva et al.
(2004) developed a multi-analyte single-membrane biosensor
for the serotype-specific detection of DENV, which showed
92% reliability in DENV serotype determination. The assay
exhibited a detection limit of 50 RNA molecules for serotype
2; 500 RNA molecules for serotypes 3 and 4; and 50,000 RNA
molecules for serotype 1, following isothermal amplification of
the target sequences. The developed biosensor can be considered
as an applicable portable, inexpensive, and easy to use tool,
representing an alternative to current detection methods based
on more expensive and time-consuming methods, such as ELISA
or tissue culture.
Although these techniques are readily available, they
are expensive and present engineering challenges regarding
miniaturization and field utilization. In addition, PCR products,
which consist of double-stranded DNA, must be denatured
before being subjected to a probe hybridization-based detection
method (Baeumner et al., 2002). In contrast, biosensors based
on liposome technology have been successfully used for the
development of rapid, inexpensive, and field-utilizable detection
systems with potential for the detection and quantification of
RNA molecules (Esch et al., 2001). We provide an update on the
development of liposome-based detection methods for DENV
or ZIKV, as the two viruses share majority of their genetic
information. Liposome-based immunoassays show applicability
in various areas of food chemistry, food microbiology, nano-
biotechnology and diagnostic or clinical microbiology, for
the detection of foodborne pathogens, toxins, and hazardous
components in a variety of environmental and human samples.
Liposome immunoassays involve a liposome-encapsulating
marker, prepared with a phospholipid composition and coupled
to either an analyte or antibody through a suitable procedure
(Shukla et al., 2012). There have been various recent advances
in methods related to liposome immunoassays, including
immunoliposome (liposome coupled to antibody)-based ELISA,
immunoliposome-based magnetic separation, and liposome-
based immunochromatographic strips used in various pathogen
detection applications. Baeumner et al. (2002) developed a
liposome biosensor-based method for the detection of DENV
that was sensitive, rapid, and serotype specific. The biosensor
assay was based on utilizing a membrane-based DNA/RNA
hybridization system with liposome amplification. The generic
DNA probe was coupled to dye-encapsulating liposomes, and
conserved or DENV serotype-specific probes were immobilized
on a polyether sulfone membrane strip. Liposomes were mixed
with the amplified target sequence and then applied to the
membrane. The mixture was allowed to migrate along the
test strip, and the liposome target sequence complexes were
immobilized in the capture zone via hybridization of the capture
probe with the target sequence. The amount of liposomes
present in the immobilized complex is directly proportional to
the amount of target sequence present in the sample and can
be quantified using a portable reflectometer (Baeumner et al.,
2002). Connelly et al. (2012) also developed a method involving
microfluidic pre-concentration coupled to liposome-based signal
amplification to efficiently detect viruses in environmental
water and clinical samples. Subsequently, an electrochemical
liposome-based assay was developed to facilitate direct detection
of virus-liposome-bead complexes using a magnet (Connelly
et al., 2012). The integrated current signals from the lysis of
captured liposomes resulted in detection of the viral titer in
an environmental sample. Although a number of established
liposome-based methods are available for the detection of
different viruses in various samples, no specific and sensitive
liposome-based detection method has been developed for
ZIKV.
Liposome-Based Detection Assays in
Medical/Clinical Use
A number of liposome-based assays are also being used in
biomedical and therapeutic applications as clinical diagnostic
assays. For pathogen detection, liposome-based lateral flow assays
coupled with nucleic acid sequence-based amplification have
been proved to represent an effective alternative for the rapid
and sensitive detection of viable bacterial pathogens (Hartlefy and
Baeumner, 2003; Baeumner et al., 2004). Edwards et al. (2010)
developed a fluorescent dye-encapsulated liposome tagged with
DNA aptamers and used it for the detection of alpha-thrombin
via an aptamer-based assay in human plasma. The advantages of
DNA aptamers over antibodies include stability; production via
inexpensive, consistent chemical synthesis; ease of modification
in terms of both labeling and selective changes in the sequence
to achieve affinity selectivity and enhanced stability; potential for
regeneration; smaller size; and production against toxic or poorly
immunogenic targets (Tombelli et al., 2005; Balamurugan et al.,
2008). In these assays, dye-encapsulating liposomes are used for
signal enhancement, providing extremely low detection limits
in the assays. In addition to fluorescent markers and enzymes,
liposomes can be used to encapsulate a variety of electrochemical
markers. Feng et al. (2010) and others (Sofou and Sgouros, 2008;
Sajja et al., 2009) developed and demonstrated the utility of a
bifunctional immunoliposome system targeting glioma cells both
in vitro and in vivo, providing the potential for drug delivery
and imaging in tumors. Lehtinen et al. (2012) also reported an
immuno-targeting system involving liposomal drug carriers to
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treat ovarian carcinoma. Additionally, immunoliposomes have
been used to deliver contrast agents and radionuclides for
diagnostic imaging and therapy (Torchilin, 2000; Erdogan et al.,
2008). Semiconductor quantum dots conjugated to liposomes are
used for imaging and the immunoliposomes have successfully
been observed in vitro and in vivo (Weng et al., 2008).
Under this subtitle, we intended to elucidate the variety of
ways in which liposomes have been used as analytical reagents
to date. These methods relying on a tagged liposome could
provide numerous ways for signaling molecules to be released
to provide a signal. Therefore, it can be stated that these
liposomes/immunoliposomes show potential for application in
various industrial and medical sectors, including for virus
detection through liposome immunoassays.
COMMERCIALLY AVAILABLE TEST KITS
FOR ZIKV DETECTION
As a future consideration, commercial serology tests will become
increasingly available for the detection of a variety of viruses.
To our knowledge, there are few commercial tests that are
expected to hit the commercial market in very near future. ZIKV
IgG or IgM ELISA kits based on utilizing a double-antigen
sandwich ELISA will be introduced by MyBiosource in USA.
However, no information on the type of antigens involved or
the specifics of validation for determining cross-reactivity is
available. Biocon Diagnostics in Canada offers a rapid finger-
prick assay based on a mixture of ZIKV NS1 and envelope protein
that can detect IgM and IgG viral antibodies. The company
indicates a specificity of 99%, but no specifications regarding the
validation procedure are given. Euroimmun in Germany offers
an IgM/IgG immunofluorescence assay and an IgM/IgG ELISA
based on a NS1 protein. The ZIKV immunofluorescence assay
is offered in a mosaic slide, together with assays for DENV1-4
and CHIKV. The provided information indicates cross-reactivity
with antibodies directed against tick-borne encephalitis virus,
West Nile virus, and DENV for both the IgG and IgM assays
(Charrel et al., 2016). Furthermore, validation data indicate a
wide range of specificities and sensitivities for the IgM and IgG
ZIKV immunofluorescence assays depending on the validation
cohort. However, the provided values are difficult to interpret as
the description of the cohorts is too brief. In addition, these data
should be interpreted with great caution as positivity was only
rated in the cut-off dilution. This could mean that the specificity
can be different than given (higher) as the results were not scored
as end-titers. The use of end-titers would provide a window for
differentiating the cross-reactivity measured. The Euroimmun
ZIKV ELISA is based on recombinant NS1 protein which leads
to a reduction of cross-reactivity with other flavivirus antibodies
to maximal values of 18.8% (IgG) and 8.3% (IgM). Euroimmun
appears to be the only manufacturer that is actually providing
detailed validation data, and its data clearly address and illustrate
the above-mentioned difficulties with cross-reactivity in flavivirus
sero-diagnostics (Euroimmun, 2016).
Musso et al. (2015) performed a molecular detection
of ZIKV in saliva samples after RNA extraction using
NucliSENS R© easyMAG R© System (BioMérieux) according to
manufacturer’s recommendations. Extracted RNA was used for
further real-time PCR detection system using two real-time
primers/probe amplification sets specific for ZIKV (Musso et al.,
2015). The analysis confirmed 210 positive results from 748
blood samples (28.1%) and 182 positive results from 319 saliva
samples (57.1%) as the overall number of real-time PCR-positive
ZIKV samples, suggesting that ZIKV RNA was more frequently
detected in saliva samples than blood samples (Musso et al.,
2015). Updated information on newly developed commercial
detection kits for ZIKV detection is given in Table 2.
RECENT RESEARCH BASED ON A
SPECIFIC HYPOTHESIS
The limitations of current diagnostic tests for ZIKV have been
described previously. These considerations highlight technical
challenges in test development and the limits of our scientific
understanding of the virus at this stage of the ZIKV response. In
our previous work, we reported polyclonal antibody production,
purification, and applicability in various liposome-based assays
(Shukla et al., 2012, 2016). There are currently no available
studies on liposome-based assays for the detection of ZIKV,
and only few such studies on DENV are available, which were
based on liposomes. Considering the various assays developed for
DENV and other viruses, we propose a strategy for developing
TABLE 2 | Update on commercially available detection kits for Zika virus.
Commercially available detection kits Company
Immunoglobulin G (IgG) and immunoglobulin M (IgM) ELISA kit for Zika virus (ZIKV) MyBiosource (USA)
Rapid finger prick assay kit (based on ZIKV nonstructural protein-1 and envelope protein) Biocon Diagnostics (Canada)
IgM and IgG immunofluorescence kit for ZIKV Euroimmun Diagnostics (Germany)
ZIKV IgM ELISA, Mac ELISA kit for ZIKV InBIOS Diagnostics (USA)
Real star ZIKV real-time polymerase chain reaction kit Altona Diagnostics (Germany)
Immunochromatographic test strips for ZIKV Tanaka Diagnostics (Japan)
Fast-Track diagnostics ZIKV test kit based on-
multiplex real-time polymerase chain reaction by TaqMan technique
Fast-Track Diagnostics (Malta)
ZIKV/DENV test kit based on RNA, qualitative real-time Reverse Transcriptase Polymerase Chain Reaction and ZIKV
antibody (IgM), MAC-ELISA
Quest Diagnostics (USA)
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a liposome-based assay for the detection of ZIKV. Thus, a
specific liposome-based assay can be applied with our developed
liposome particles to develop a liposome-based detection system
for analyzing ZIKV in clinical samples using anti-ZIKV antibody.
In several reports, we have described the principle of various
liposome-based assays for detecting pathogens (Shin and Kim,
2008; Shukla et al., 2012, 2016). Liposome immunoassays involve
a liposome-encapsulating marker (sulforhodamine B dye) and
are prepared with a phospholipid composition, coupled to
either an analyte or antibody through a suitable procedure
(Shukla et al., 2012, 2016), after which the assay is carried
out in a routine manner. The detectable signal of these
assays is produced upon the lysis of the liposome and the
release of the encapsulated markers. Shin and Kim (2008)
reported that as the size of the liposomes increased, a higher
fluorescence signal was obtained due to a greater number
of sulforhodamine B molecules encapsulated in the liposome.
Various advanced methods related to immunoliposome assays
have recently been developed, including immunoliposome-
coupled ELISA, immunoliposome-coupled magnetic separation,
and immunoliposome-based immunochromatographic strips
used in various applications.
A predicted model of liposome-based immunochromato-
graphic strips for viral detection is summarized in Figure 3.
Briefly, the assay will involve an antigen capture zone
(test line) on a nitrocellulose membrane strip, which is
exposed to the target antigen, consisting of a virus particle
in a solution containing immunoliposome. Liposomes are
encapsulated in sulforhodamine B and tagged with anti-ZIKV
antibody specific for the binding of the specific ZIKV particle.
In the presence of the ZIKV particle, the immunoliposome
and ZIKV particle complex migrates along the test strip
via capillary action and subsequently binds to the capture
antibody zone of the membrane, producing a purple band.
However, some of the immunoliposomes do not bind the
ZIKV particles at the test line and continue to migrate
and bind to the control line of membrane, resulting in the
development of a purple band, showing a positive result for
the presence of ZIKV particles (Figure 3). In the absence
of ZIKV particles in test samples, the immunoliposomes
are not able to bind to the specific antigen (ZIKV) and
they therefore migrate and bind at control line of the test
membrane, leading to the development of a purple line in
the control line only, confirming a negative result for ZIKV
particle detection (Figure 3). In addition, there is another
simple liposome-based detection strategy utilizing a liposome
immunoassay, in which detection is measured via the lysis
of liposome particles (Shukla et al., 2016). Sulforhodamine
B is a self-quenching molecule when encapsulated at a
high concentration within lipid and phospholipid vesicles to
form sulforhodamine B-encapsulated liposomes. Therefore, the
integrity of the sulforhodamine B-encapsulated antibody-tagged
liposomes with a target virus particle can be determined
by measuring the increase in fluorescence after lysis of
the immunoliposome particles (Figure 4). Furthermore, there
might be another strategy for developing a combined assay
involving immunoliposomes and immunomagnetic particles
for the sensitive detection of ZIKV particles as shown in
Figure 5. The assay procedure can be divided into the following
three steps: immunomagnetic concentration and separation
of target ZIKV; reaction of the immunoliposome particles
with virus particles attached to immunomagnetic nanoparticles;
FIGURE 3 | Research theme for developing liposome-based immunochromatographic strips for specific Zika virus.
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FIGURE 4 | Strategy for developing liposome immunoassay-based fluorescence immunoassay for the detection of Zika virus.
FIGURE 5 | Strategy for developing immunoliposome and immunomagnetic particle-based sensitive detection of Zika virus. (Retrieved from Shukla
et al., 2016).
and fluorescence signal generation, as the principle of the
developed assay discussed in our earlier research (Shukla et al.,
2016).
Another important possibility is the development of liposome-
based multiplexing that would allow simultaneous detection of
several similar gene sequences of viral pathogens in a single
sample, particularly for ZIKV, DENV, and CHIKV. In addition
to ZIKV, DENV, and CHIKV, the choice of pathogens for a
multiplexed diagnostic tool should consider clinically consistent
presentations. Not all pathogens will be relevant to all settings;
nonetheless, the need to differentiate CHIKV, DENV, and ZIKV
for both clinical and epidemiologic purposes is of immediate
importance and is likely to remain relevant in the future. In
multiplexed assays, and particularly those that measure RNA
from CHIKV, DENV, and ZIKV, it is important that the analytical
sensitivity for ZIKV not be compromised. Possibilities for the
interpretation of such multiplexing liposome-based kits, such as
those involving immunochromatographic strips, are illustrated
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FIGURE 6 | Result interpretation of immunochromatographic strip assay for simultaneous detection of Zika, Chikungunya, and Dengue viruses.
in Figure 6. To obtain accurate results in multiplexing assays
that may be based on liposome-based immunochromatographic
strips, the development of a common antibody against ZIKV,
DENV, and CHIKV might provide useful results. Multiplex
tests should be able to detect the ZIKV antibodies in cases
of concurrent infection with both pathogens, and the analytic
limit of detection for ZIKV antibodies should be the same
for singleplex and multiplex tests. Multiplexing using dual
analytes in a single test (e.g., nucleic acid and immunoassay
testing) (Chen and Zhu, 2016) may also greatly improve
the diagnosis of acute ZIKV infection. For example, a test
that could simultaneously detect both ZIKV RNA and anti-
ZIKV IgM would cover the entire time period of acute ZIKV
infection and might be particularly useful given the limited
reliability of patient self-reporting of the onset of fever and other
symptoms.
Although few antibody-based ZIKV detection kits are
available, we have presented a potentially easy method for the
development of pathogen detection kits based on laboratory-
produced antibodies and liposomes, which could provide
a cheaper alternative for pathogen detection compared
with expensive commercial pathogen detection kits. In the
near future, studies should attempt to confirm the practical
applications of liposome-based virus detection assays in various
food samples contaminated with foodborne viruses, including
ZIKV.
SAFETY PRECAUTIONS FOR
LABORATORIES WORKING ON ZIKV
Regarding laboratory safety, ZIKV is classified as a biological
safety level 2 pathogenic agent. These pathogens must be
handled according to the biosafety guidelines of microbiological
and biomedical laboratories, and risk assessment should be
performed for each laboratory for any specific procedure used
in the laboratory. Because of the major concern regarding
congenital microcephaly and ZIKV infection, precautions
should be taken by pregnant women while working in the
laboratory, and regular ZIKV testing should be maintained in
the laboratory. The CDC recommends that each laboratory
should perform risk assessment when implementing any new
viral methodology in the laboratory as a safety precaution
(Centers for Disease Control and Prevention [CDC],
2016a).
CONCLUSION
The widespread ZIKV epidemic in the Americas and Asia
has led to the urgent need to develop rapid, sensitive, and
specific assays for virus detection with regular monitoring of
viral infection. Rapid detection of the virus in field-collected
specimens can accelerate the application of appropriate mosquito
control measures that could prevent transmission and disease
among human populations. Early diagnosis of ZIKV infection,
supportive care, symptomatic treatment, and referral of children
with microcephaly to specialized care are all necessary measures
to improve the neuro-development of affected children. The
hypothesis and strategies that we have presented herein provide
a relevant platform, emphasizing the importance of liposome-
based detection methods in ZIKV diagnosis for improving global
health. In overall view, the best advantage of these hypothesized
assays is easy handling, no requirement of any sophisticated
instruments, rapid detection efficacy, and cost effectiveness than
other molecular approaches. On the other side, major limiting
factor of these hypothesized assays especially for the detection
of viral infections including ZIKV, DENV, and others is their
antigen-antibody-based detection ability. Identification of major
antigenic and protective epitopes of the target virus particles
importantly needed to understand the antibody response while
developing these detection strategies. In brief, virus particles
can easily go for mutation, and antigenic variations by which
an infectious virus alters its surface proteins called antigenic
structure eventually result in the differentiation of virus strains.
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These antigenic variations make difficulty in the process
of specific antibody production, thus, may affect in the
developmental process of these diagnostic assays. In conclusion,
the present review summarizes and updates the methods available
for the detection of ZIKV in human clinical samples. New
insights and interpretations should be obtained by studying the
mechanisms of several similar detection strategies that are being
developed. Innovative approaches based on liposome particles
should be of interest for the detection of ZIKV, particularly in
relation to previously developed liposome-based strategies, which
may provide new insights for future research and strategies for
the development of fast and sensitive assays for ZIKV infections.
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